![Philip L. Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philip L. Smith
Director/Miembro de la Junta en
REDPOINT BIO CORPORATION
.
Perfil
Philip L.
Smith is currently a Director at Linguagen Corp., Trinity Biosystems, Inc., and Mid-Atlantic Capital Alliance.
Previously, he held positions as a Director at Robcor Properties, Inc., GlaxoSmithKline Pharmaceuticals Ltd., Dr. Reddy's Research & Development BV, Avantium Technologies BV, Onyvax Ltd., and GSK Equity Investments Ltd. He has also pursued his education, earning graduate and doctorate degrees from Northeastern University and an undergraduate degree from the University of Maine.
Cargos activos de Philip L. Smith
| Empresas | Cargo | Inicio |
|---|---|---|
| REDPOINT BIO CORPORATION | Director/Miembro de la Junta | - |
Mid-Atlantic Capital Alliance | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Philip L. Smith.
| Empresas | Cargo | Fin |
|---|---|---|
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Develops injectable formulations and drugs | Director/Miembro de la Junta | 12/05/2010 |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Inversor de Capital Privado | 31/01/2009 |
Robcor Properties, Inc.
 Robcor Properties, Inc. Real Estate DevelopmentFinance Owns and leases industrial buildings | Director/Miembro de la Junta | 05/07/2007 |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Corporate Officer/Principal | 01/06/2002 |
Avantium Technologies BV
 Avantium Technologies BV Chemicals: SpecialtyProcess Industries Manufactures recyclable polymers | Director/Miembro de la Junta | - |
Formación de Philip L. Smith.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
42
Relaciones de 1er grado
11
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 11 |
|---|---|
Robcor Properties, Inc.
Robcor Properties, Inc. Real Estate DevelopmentFinance Owns and leases industrial buildings | Finance |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
GlaxoSmithKline Pharmaceuticals Ltd.
 GlaxoSmithKline Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the business of manufacturing, distributing and trading in pharmaceuticals | Health Technology |
Dr. Reddy's Research & Development BV
Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Develops injectable formulations and drugs | Health Technology |
Avantium Technologies BV
Avantium Technologies BV Chemicals: SpecialtyProcess Industries Manufactures recyclable polymers | Process Industries |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maine
 University of Maine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Onyvax Ltd.
 Onyvax Ltd. Miscellaneous Commercial ServicesCommercial Services Develops cancer remedy therapies | Commercial Services |
Linguagen Corp.
 Linguagen Corp. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in the field of flavor discovery & modification | Commercial Services |
Trinity Biosystems, Inc.
 Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Develops and formulates orally delivered bio-therapeutic macromolecules | Health Technology |
Mid-Atlantic Capital Alliance |
- Bolsa de valores
- Insiders
- Philip L. Smith
